Literature DB >> 26433015

How complicated can it be? The link between APOL1 risk variants and lipoprotein heterogeneity in kidney and cardiovascular diseases.

Chien-An A Hu1, Patricio E Ray2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26433015      PMCID： PMC4902870          DOI： 10.1093/ndt/gfv357

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  30 in total

1.  Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy.

Authors:  J D Otvos; E J Jeyarajah; D W Bennett
Journal:  Clin Chem       Date:  1991-03       Impact factor: 8.327

2.  African American living-kidney donors should be screened for APOL1 risk alleles.

Authors:  David M Cohen; Anuja Mittalhenkle; David L Scott; Carlton J Young; Douglas J Norman
Journal:  Transplantation       Date:  2011-10-15       Impact factor: 4.939

3.  Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of apolipoprotein L.

Authors:  P N Duchateau; C R Pullinger; R E Orellana; S T Kunitake; J Naya-Vigne; P M O'Connor; M J Malloy; J P Kane
Journal:  J Biol Chem       Date:  1997-10-10       Impact factor: 5.157

4.  The APOL1 gene and allograft survival after kidney transplantation.

Authors:  A M Reeves-Daniel; J A DePalma; A J Bleyer; M V Rocco; M Murea; P L Adams; C D Langefeld; D W Bowden; P J Hicks; R J Stratta; J-J Lin; D F Kiger; M D Gautreaux; J Divers; B I Freedman
Journal:  Am J Transplant       Date:  2011-04-12       Impact factor: 8.086

5.  Cubilin maintains blood levels of HDL and albumin.

Authors:  Obaidullah Aseem; Brian T Smith; Marion A Cooley; Brent A Wilkerson; Kelley M Argraves; Alan T Remaley; W Scott Argraves
Journal:  J Am Soc Nephrol       Date:  2013-12-19       Impact factor: 10.121

6.  Apolipoprotein L-I is the trypanosome lytic factor of human serum.

Authors:  Luc Vanhamme; Françoise Paturiaux-Hanocq; Philippe Poelvoorde; Derek P Nolan; Laurence Lins; Jan Van Den Abbeele; Annette Pays; Patricia Tebabi; Huang Van Xong; Alain Jacquet; Nicole Moguilevsky; Marc Dieu; John P Kane; Patrick De Baetselier; Robert Brasseur; Etienne Pays
Journal:  Nature       Date:  2003-03-06       Impact factor: 49.962

7.  Apolipoprotein L1: from obscurity to consistency to controversy.

Authors:  Michael S Lipkowitz
Journal:  Kidney Int       Date:  2015-01       Impact factor: 10.612

8.  ApoL1, a BH3-only lipid-binding protein, induces autophagic cell death.

Authors:  Siqin Zhaorigetu; Guanghua Wan; Ramesh Kaini; Zeyu Jiang; Chien-an A Hu
Journal:  Autophagy       Date:  2008-11-23       Impact factor: 16.016

9.  Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.

Authors:  Shay Tzur; Saharon Rosset; Revital Shemer; Guennady Yudkovsky; Sara Selig; Ayele Tarekegn; Endashaw Bekele; Neil Bradman; Walter G Wasser; Doron M Behar; Karl Skorecki
Journal:  Hum Genet       Date:  2010-07-16       Impact factor: 4.132

10.  Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1.

Authors:  Brendan Nichols; Prachi Jog; Jessica H Lee; Daniel Blackler; Michael Wilmot; Vivette D'Agati; Glen Markowitz; Jeffrey B Kopp; Seth L Alper; Martin R Pollak; David J Friedman
Journal:  Kidney Int       Date:  2014-08-06       Impact factor: 10.612
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.